跳至主要内容
临床试验/JPRN-UMIN000002402
JPRN-UMIN000002402已完成3 期

Study of effects of Nobelzin capsules (zinc acetate) on hyperammonemia in patients with liver cirrhosis; A randomized, double-blind, placebo-controlled study in patients with liver cirrhosis - Effects of Zinc supplementation on Hyperammonemia in patients with Liver Cirrhosis (EZ trial)

Ministry of Health, Labour and Welfare0 个研究点目标入组 50 人开始时间: 2009年9月15日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

This is the first randomized-controlled trial to show that zinc supplementation for 3 months seems effective and safe for treating hyperammonemia in liver cirrhosis.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Hepatic coma grade >= 3 2.Fulminant hepatitis 3.Patients with malignant diseases who need to be treated during the period of this trial 4.Patients with cardiac, renal or pancreatic diseases who need admission for the therapy 5.Patients who are associated with heavy hematological disorders or cerebrovascular diseases 6.Known or suspected history of allergy to zinc 7.Inegible patients at a physician's discretion

研究者

相似试验